Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Avi Weissman"'
Autor:
Avi Magid, Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Netanel A. Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas
Publikováno v:
Antibodies, Vol 13, Iss 3, p 63 (2024)
Background: Previous studies showed that the fourth SARS-CoV-2 vaccine dose has a protective effect against infection, as well as against severe disease and death. This study aimed to examine whether knowledge of a high-level antibody after the third
Externí odkaz:
https://doaj.org/article/6feb34e525aa48eaa6caf2908edfa1f8
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
OverviewRecall is an accepted consequence of sedation. But due to the very low prevalence of the more devastating awareness under anesthesia (AUA), it might be of value to assess first the efficacy of new markers for AUA by their efficacy in discover
Externí odkaz:
https://doaj.org/article/355a5298090e4b76ad6592ff70ea7419
Autor:
Khetam Hussein, Yael Shachor-Meyouhas, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Jalal Tarabeia, Avi Weissman, Michal Mekel, Gila Hyams, Michael Halberthal
Publikováno v:
Rambam Maimonides Medical Journal, Vol 13, Iss 2, p e0011 (2022)
Background: With the availability of coronavirus disease 2019 (COVID-19) vaccine, concerns have been raised regarding pre-vaccination seroprevalence in healthcare workers (HCW). This study examines the seroprevalence of HCW at an Israeli tertiary med
Externí odkaz:
https://doaj.org/article/142311ef807848438d121b94cb2830d4
Autor:
Yael Shachor-Meyouhas, Halima Dabaja-Younis, Avi Magid, Ronit Leiba, Moran Szwarcwort-Cohen, Ronit Almog, Michal Mekel, Avi Weissman, Gila Hyams, Vardit Gepstein, Nethanel A. Horowitz, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Khetam Hussein
Publikováno v:
Vaccines, Vol 11, Iss 2, p 283 (2023)
Introduction: The fourth SARS-CoV-2 vaccine dose was found to protect against infection and more importantly against severe disease and death. It was also shown that the risk of symptomatic or severe disease was related to the antibody levels after v
Externí odkaz:
https://doaj.org/article/d22a835f0ef34a94b8e2e3f98eb189bb
Autor:
Khetam Hussein, Halima Dabaja-Younis, Moran Szwarcwort-Cohen, Ronit Almog, Ronit Leiba, Avi Weissman, Michal Mekel, Gila Hyams, Nethanel A. Horowitz, Vardit Gepstein, Hagar Cohen Saban, Jalal Tarabeia, Michael Halberthal, Yael Shachor-Meyouhas
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1741 (2022)
This study assessed humoral response to the third BNT162b2 dose among healthcare workers (HCW). This prospective cohort study of HCW tested for anti-spike antibodies (LIAISON SARS-CoV-2 S1/S2 IgG assay) at 1, 3, 6, 9, and 12 months after receiving th
Externí odkaz:
https://doaj.org/article/e122aafc9b7b4ade9fe7b2942aa93910
Autor:
Eyal, Braun, Netanel A, Horowitz, Ronit, Leiba, Avi, Weissman, Michal, Mekel, Yael, Shachor-Meyouhas, Khetam, Hussein, Michael, Halberthal, Zaher S, Azzam, Gidon, Berger
Publikováno v:
Clinical Microbiology and Infection. 28:1644-1648
This study sought to correlate the SARS-CoV-2 IgG antibody response level to the BNT162b2 (Pfizer BioNTech) mRNA vaccine after the first and second doses with the reported adverse events.This cohort study examined the adverse events profiles of peopl
Autor:
Halima K. Dabaja-Younis, Vered Schechner, Ibrahim Firan, Iyad Khamaysi, Gabrielle D. Levi, Mor N. Lurie-Weinberger, Avi Weissman, Yuri Guriel, Yuval Geffen, Khetam Hussein
Publikováno v:
Infection Control & Hospital Epidemiology. :1-3
We report 2 outbreaks of genetically unrelated carbapenem-resistant New Delhi metallo-β-lactamase–producing Escherichia coli caused by contaminated duodenoscopes. Using endoscopes with disposable end caps, adherence to the manufacturer’s reproce
Autor:
Avi Magid, Netanel Horowitz, Ronit Almog, Yael Shachor-Meyouhas, Avi Weissman, Michael Halbertal, Michal Mekel
Publikováno v:
Population Medicine. 5
Autor:
Michael Halberthal, Yael Shachor-Meyouhas, Gila Hyams, Michal Mekel, Marielle Kaplan, Moran Szwarcwort-Cohen, Khetam Hussein, Netanel A. Horowitz, Avi Weissman, Halima Dabaja-Younis
Publikováno v:
Vaccine
Introduction The coronavirus disease 2019 (COVID-19) pandemic has led to worldwide vaccination development efforts. In December 2020 the Pfizer BNT162b2 vaccine was approved in the United States. This study describes the first BNT162b2 vaccine dose e
Autor:
Michal Mekel, Moran Szwarcwort-Cohen, Ronit Almog, Michael Halberthal, Jalal Tarabeia, Halima Dabaja-Younis, Nethanel A. Horowitz, Khetam Hussein, Vardit Gepstein, Neta Petersiel, Avi Weissman, Hagar Cohen Saban, Yael Shachor-Meyouhas, Itamar Netzer, Gila Hyams
Publikováno v:
Clinical Microbiology and Infection. 28:450.e1-450.e4
Objectives We evaluated antibody response to the BNT162B2 vaccine among healthcare workers (HCWs) to identify factors associated with decreased immunogenicity. Methods This prospective cohort study included consenting HCWs who completed a questionnai